@360-days: CR = 53% ... TR = 79%What the 2nd dose given @180-days then gives @360-days ...
This pool of patient already excludes 10 patients (the 10 in red that never made it to 180-days). Always with the aim of better assessing what our optimized group could deliver in terms of efficacy.
19 Ph. 2 evaluable patients @360-days
4 out of 19 = 21% NR @360-days
10 out of 19 = 53% CR @360-days
5 out of 19 = 26% IR @360-days
22 out of 19 = 79% TR @360-days